About Us  |  Contact Us  |  Español
Butler Hospital
Butler Hospital

Organizations Butler
Research Type Clinical
Therapeutic Area of Study Parkinson's Disease/Movement Disorders
Principal Investigators
Eligibility Criteria Male or female 30 years or older with early Parkinson’s disease who are not yet on treatment for Parkinson’s
Recruitment Status Open
Date Study Started 07/01/2007
Date Study Ends 07/01/2014
Contact Information

For more information contact Lisa at 401-455-6667.

Description

This study is using oral inosine to try to slow the progression of Parkinson’s disease in those with early PD. Inosine raises serum uric acid, which, by strong epidemiological evidence, is associated with reduced incidence of PD and slow progression. This study lasts approximately 2 years with 16 visits over that time period. This study is sponsored by the Michael J. Fox Foundation

Look for another study
Health Headlines
FDA Panel: Limit Testosterone Drug UseView in a lightbox
New Ebola Cases Top 700 in Just One Week, Officials ReportView in a lightbox
Obama Calls for National Plan to Fight Antibiotic ResistanceView in a lightbox
Mentors May Steer Young People Toward More Rewarding CareersView in a lightbox
ER Waiting Times Vary Significantly, Studies FindView in a lightbox
Butler Hospital
© 2011 Site Index | Disclaimer | Legal Notices | Talks Your Health